All posts
-
Gold Price Forecast: XAU/USD prints fresh record before consolidating below $4,600
Gold (XAU/USD) trades around $4,580 on Monday at the time of writing, up 1.60% on the day. The precious metal reached a new all-time high at $4,601.32 earlier in the day, extending…
-
Scaling out, not up: foodtech leaders rethink growth at Tufts event as capital dries up
In what sometimes seemed like a team treatment session, foodtech leaders put together at the Tufts Future of Food Innovation Day in Boston talked openly regarding a “traumati…
-
Exclusive: Biographica raises $9.5m for AI-driven crop design, unveils partnership with BASF
Biographica, a startup deploying AI and machine learning to accelerate and improve the crop trait development process by identifying high value targets for gene-editing, has raised…
-
Apple chooses Google’s Gemini AI to power Siri
Technology titans Apple and Google revealed Monday a multi-year collaboration that will certainly see Apple’s next-generation expert system attributes, including its Siri cha…
-
I used AI chatbots as a source of news for a month, and they were unreliable and erroneous
It was charming. However it was still a lie. Gemini designed an information electrical outlet that does not exist and called it fake-example. ca (or exemplefictif.ca, in French).
-
In charts: why Rio Tinto and Glencore are in talks about a megamerger
The recommended $260bn tie-up would certainly develop the globe’s most significant copper manufacturer each time of rising need for the steel
-
Novo Nordisk: Up to 1.5 million patients users on copies in the USA
Mike Doustdar stated on monday that as much as 1.5 million American individuals make use of duplicate medications from “compounders” of GLP-1 drug.
-
Nvidia and Eli Lilly collaborate on AI laboratory
Drug gigantic Eli Lilly has actually partnered with chip gigantic Nvidia on a brand-new lab.
-
Boston Scientific gains access to FDA-approved product through US acquisition
With Valencia Technologies’ Ecoin system, Boston Scientific is targeting a brand-new dental implant market.
-
Danske Bank: Coloplast’s Kerecis may gain market shares following new pricing policy in the US
Coloplast’s Kerecis is positioned to acquire market shares in the United States. New rates plan supplies greater aids than the ordinary cost for injury treatment items.
